Xxec, Inc. Catalent, Inc. Transaction History

Xxec, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$72.36 - $113.1 $59,624 - $93,194	-824 Reduced 1.14%	71,416 $5.17 Million
Q2 2022 Jul 26, 2022	SELL	$87.2 - $114.05 $270,494 - $353,783	-3,102 Reduced 4.12%	72,240 $7.75 Million
Q1 2022 Apr 12, 2022	BUY	$94.19 - $124.49 $2.07 Million - $2.74 Million	21,992 Added 41.22%	75,342 $8.5 Million
Q4 2021 Feb 02, 2022	BUY	$119.57 - $139.07 $2.38 Million - $2.77 Million	19,900 Added 59.49%	53,350 $5.35 Million
Q3 2021 Oct 19, 2021	SELL	$109.17 - $142.35 $96,615 - $125,979	-885 Reduced 2.58%	33,450 $4.45 Million
Q2 2021 Aug 13, 2021	BUY	$100.34 - $115.69 $1.75 Million - $2.02 Million	17,435 Added 103.17%	34,335 $3.71 Million
Q4 2020 Feb 17, 2021	BUY	$85.88 - $105.36 $1.45 Million - $1.78 Million	16,900 New	16,900 $1.76 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Xxec, Inc., based on Form 13F filings with the SEC.

Stay updated on Xxec, Inc. with notifications on news.